Use of Drug in a Difficult-to-Treat Disease Not Obvious Without Proof of Efficacy
OSI Pharma v. Apotex Inc. (Fed. Cir. 2019) In a decision issued recently, the Federal Circuit reversed the Patent Trial…
Read more
McBee Moore & Vanik IP, LLC
Patent, Trademark & Intellectual Property Law Firm
Daily Archives: October 24, 2019
You are here: